Bayer to buy BIVI's Cydectin parasiticidesDecember 13, 2016Bayer Animal Health of Shawnee, Kan., will acquire BIVI’s Cydectin (moxidectin) line, which is formulated to control parasites in cattle and sheep, the companies announced Dec. 7.
Education Center - SponsoredRethinking Our Approach to Canine OA: Treating synovial inflammationby • Exubrion TherapeuticsIt’s time to reframe arthritis not just as a painful condition, but as a disease of rampant synovial inflammation. In adopting a proactive treatment strategy that is aimed at modulating the inflammatory process, veterinarians can now provide more effective, long-term care.
